Glycoprotein IIb/IIIa receptor inhibitors: putting the EPIC, IMPACT II, RESTORE, and EPILOG trials into perspective.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/4DECC83C.svg?ark=w1%2F20260515%2F4DECC83C)](https://nobleid.org/work/w1/20260515/4DECC83C)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors